Chronic prehepatic portal hypertension in rats by triple stenosing ligation of the portal vein;Hipertensión portal prehepática crónica en la rata por triple ligadura estenosante portal

Cirugia Espanola

Volumn 69, Issue 2, 2001, Pages 103-107

  Aller Reyero, M A ^a   Nava Hidalgo, M P ^a   Dieguez Fernandez B ^a   Palma Mezquida, M D ^a   Arias Perez J L ^b   Arias Perez J ^a  

^a UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

^b UNIVERSITY OF OVIEDO   (Spain)

Author keywords

Portal hypertension; Rats

Indexed keywords

EID: 84897585323     PISSN: 0009739X     EISSN: 1578147X     Source Type: Journal    
DOI: 10.1016/S0009-739X(01)71704-6     Document Type: Article

References (24)

1. Bosch J. Medical treatment of portal hypertension. Digestion 1998; 59: 547-555.
2. Lebrec D. Pharmacological treatment of portal hypertension: present and future. J Hepatol 1998; 28: 896-907.
3. Ianniti DA, Henderson JH. Surgery in portal hypertension. Baill Clin Gastroenterol 1997; 11: 351-364.
4. Chojkier M, Groszmann RJ. Measurement of portal-systemic shunting in the rat by using ©-labeled microspheres. Am J Physiol 1981; 240: G371-G375.
5. Groszmann RJ, Vorobioff J, Riley E. Measurement of splanchnic hemodynamics in portal hypertensive rats: application of ©-labeled microspheres. Am J Physiol 1982, 242: G156-G160.
6. Vorobioff JE, Bredfeldt JE, Groszmann RJ. Hyperdynamic splanchnic circulation in portal hypertensive rat model: a primary factor for maintenance of chronic portal hypertension. Am J Physiol 1983; 244: G52-G57.
7. Sikuler E, Kravetz D, Groszmann RJ. Evolution of portal hypertension and mechanisms involved in its maintenance in a rat model. Am J Physiol 1985; 248: G618-G625.
8. Sikuler E, Groszmann RJ. Hemodynamic studies in long- and shortterm portal hypertensive rats: the relation to systemic glucagon levels. Hepatology 1986; 6: 414-418.
9. Monterde G, Rodríguez-Fabian G, Vara E, López L, Arias JL, Aller MA et al. Increased plasma levels of corticosterones and prolactin and decreased T3 and T4 levels in short-term prehepatic portal hypertension in rats. Dig Dis Sci 2000; 45: 1865-1871.
10. Rodríguez Gómez J, Rodríguez Fabian G, Aller Reyero MA. Normas éticas para el cuidado y utilización de los animales de experimentación. Cir Esp 2000; 67: 10-13.
11. Rodríguez-Fabian G, Monterde G, Diéguez B, Aller MA, Arias J. Hipertensión portal a largo plazo en la rata por triple ligadura estenosante de la vena porta. An Med Int 2000; 17: 137-141.
12. Green LC, Wayner DA, Glogowski J, Skipper PL, Wishnock JS, Tannenbaum SR. Analysis of nitrate, nitrite and (15N) nitrate in biological fluids. Anal Biochem 1982; 126: 131-135.
13. Meng XD, Sawamura K, Tawai K, Hanada K, Ishida H, Hashimoto I. Keratycocyte gene therapy for systemic diseases. Circulating interleukin 10 released from gene-transferred keratynocytes inhibits contact hypersensitivity at distance areas of the skin. J Clin Invest 1998; 101: 1462-1467.
14. Canty TG, Jauregizar E, Fernández-Cruz L. Experimental portal hypertension in the rat. J Pediatr Surg 1980; 15: 819-826.
15. Díez-Arias JA, Aller MA, Gragera R, Muñiz E, Arias J. Portal hypertensive duodenopathy in the rat. Surg Res Comm (en prensa).
16. Misra V, Misra SP, Dwivedi M, Gupta S. Histomorphometric study of portal hypertensive enteropathy. Am J Clin Pathol 1997; 108: 652-657.
17. Lin P-W, Shan Y-S. Effects of splenectomy on portal pressure in short- and long-term portal hypertension. J Formosan Med Assoc 1992; 91: 487-490.
18. Lin P-W, Shan Y-S. Effects of splenectomy and splenic artery ligation on the portal pressure in portal hypertensive rats. J Surg Res 1992; 56: 621-624.
19. López Talavera JC, Merrill WW, Groszmann RJ. Tumor necrosis factor 〈: a major contributor to the hyperdynamic circulation in prehepatic portal hypertensive rats. Gastroenterology 1995; 108: 761-767.
20. López Talavera JC, Cadelina G, Dichowski J, Merrill W, Groszmann RJ. Thalidomide inhibits tumor necrosis factor 〈 , decreases nitric oxide synthesis and ameliorates the hyperdynamic circulatory syndrome in portal-hypertensive rats. Hepatology 1996; 23: 1616-1621.
21. West R, Groszmann RJ. Nitric oxide and portal hypertension: its role in the regulation of intrahepatic and splanchnic vascular resistance. Sem Liver Dis 1999; 19: 411-426.
22. Sieber C, Sumanovski LT, Battegay E. Increased role of nitric oxide angiogenesis in chronic portal hypertensive rats. Hepatology 1999; 29: 1044-1049.
23. Lalani I, Bhol K, Ahmed R. bInterleuquina-10: biology, role in inflammation and autoimmunity. Ann Allergy Asthma Immunol 1997; 79: 469-484.
24. Borish L. IL-10: evolving concepts. J Allergy Clin Immunol 1998; 101: 293-297.